The Multidisciplinary Association for Psychedelic Studies (MAPS) has been awarded a US$12,979,050 ($16,254,183) grant to continue its investigation into the treatment of post-traumatic stress disorder (PTSD) with cannabis.
Story continues below
This advertisement has not loaded yet, but your article continues below.
The funding will allow the non-profit research and educational organization to conduct a second randomized, controlled trial to test the therapeutic potential of cannabis as a treatment for PTSD in U.S. veterans.
The funding arrives via Michigan’s US$20 million competitive 2021 Veteran Marijuana Research Grant Program.
Recreational cannabis taxes fund the program, which is designed to evaluate “the efficacy of marijuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”
Read full article on The Growth Op